Chemistry: analytical and immunological testing – Involving diffusion or migration of antigen or antibody
Reexamination Certificate
2005-10-18
2005-10-18
Smith, Lynette R. F. (Department: 1645)
Chemistry: analytical and immunological testing
Involving diffusion or migration of antigen or antibody
C435S001200, C435S007100, C435S007200, C435S007800, C435S009000, C435S029000, C435S040510, C435S040520, C435S325000, C435S326000, C435S330000, C435S332000, C435S344100, C435S371000, C435S375000, C435S173900, C424S574000
Reexamination Certificate
active
06955924
ABSTRACT:
The instant invention provides for the identification, diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto.
REFERENCES:
patent: 6294356 (2001-09-01), Jones et al.
patent: WO 00/26342 (2000-05-01), None
patent: WO 00/34441 (2000-06-01), None
patent: WO 01/87239 (2001-11-01), None
Giannelli et al. 1997. Science. vol. 277: 225-228.
Seaver. 1994. Genetic Engineering. 14(14):10 and 21.
Aberdam et al., (1994), Nature Genetics, “Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMANIN-5)”, vol: 6: pp. 299-304.
Amano, et al., (2000), The Journal of Biological Chemistry, “Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain”, vol: 275(30), pp. 22728-22735.
Anderson, et al., (2001), The Laryngoscope, “Tumor deposition of laminin-5 and the relationship with perineural invasion”, vol: 111, pp. 2140-2143.
Calaluce, et al., (2001), Molecular Carcinogenesis, “Laminin-5-mediated gene expression in human prostate carcinoma cells”, vol: 30, pp. 119-129.
Davis, et al., (2001), The Prostate, “Unique expression pattern of the α6β4 integrin and Laminin-5 in human prostate carcinoma”, vol: 46, pp. 240-248.
Engvall, et al., (1990), Cell Regulation, “Distribution and isolateion of four laminin variants; tissue restricted distribution of heterotrimers assembled from five subunits”, vol: 1, pp. 731-740.
Fukushima, et al., (2001), Mod. Pathol., “Expression of laminin-5-γ-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas”, vol: 14(5), pp. 404-409.
Gianelli, et al., (1997), Science, “Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5”, vol: 277, pp. 225-228.
Gianelli and Antonaci, (2001), Clinical and Experimental Metastasis, “Biological and Clinical Relevance of Laminin-5 in Cancer”, vol: 18, 439-443.
Goldfinger, et al., (1998), J. Cell Biol., “Processing of Laminin-5 and its functional consequences: Role of Plasmin and Tissue-type Plaminogen Activator”, vol: 141, pp. 255-265.
Gonzales, et al., (1999), Mol. Biol. of the Cell, “A cell signal pathway involving laminin-5, α3β1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation”, vol: 10, pp. 259-270.
Grassi, et al., (1999), Journal of Cell Science, “The SFL activity secreted by metastatic carcinoma cells is related to laminin 5 and mediates cell scattering in an integrin-independent manner”, vol: 112, pp. 2511-2520.
Haas, et al., (2001), The Journal of Histochemistry & Cytochemistry, “A comparative quantitative analysis of laminin-5 in the basement membrane of normal, hyperplastic, and malignant oral mucosa by confocal immunofluorescence imaging”, vol: 49(10), pp. 1261-1268.
Habermann, et al., (2001), Scand J. Gastroenterol, “Ulcerative colitis and colorectal carcinoma”, vol: 7, pp. 751-758.
Hao, et al., (1996), American Journal of Pathology, “Differential expression of laminin 5 (α3β3γ2) by human malignant and normal prostate”, vol: 149(4):, pp. 1341-1349.
Heagerty, et al., (1986), Lancet, “GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa”, vol: 860, p. 8485.
Heagerty, et al., (1987), British J. Dermatol, “Raid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody”, vol: 17, pp. 271-275.
Hellman, et al., (2000), Int. J. Gynecol. Cancer., “Cancer of the vagina: Laminin-5γ2 chain expression and prognosis”, vol: 10, pp. 391-396.
Henning, et al., (1999), Histopathology, “Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast”, vol: 34, pp. 305-309.
Hlubek, et al., (2001), Cancer Research, “Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin1”, vol: 61, pp. 8089-8093.
Hsi, et al., (1986), J. Reprod. Immunology, “Monoclonal antibodies to human amnion”, vol: 9, pp. 11-21.
Kagesato, et al., (2001), Japan J. Cancer Research, “Sole expression of laminin γ2 chain in invading tumor cells and its associateion with stromal fibrosis in lung adenocarcinomas”, vol: 21, pp. 184-192.
Katoh, et al., (2002), Oncology, Correlation between laminin-5 γ2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue, vol: 62, pp. 318-326.
Kallunki, et al., (1992), J. Cell Biol., “A truncated laminin chain homologous to the B2 chain: Structuree, spatial expression, and chromosomal assignment”, vol: 118, pp. 679-693.
Koshikawa, et al., (1999), Cancer Research, Overexpression of laminin γ2 chain monomer in invading gastric carcinoma cells, vol: 59, pp. 5596-5601.
Lenander, et al., (2001), Analytical Cellular Pathology,“Laminin-5 γ2 chain expression correlates with unfavorable prognosis in colon carcinomas”, vol: 22, pp. 201-209.
Lohi, et al., (2000), APMIS, “Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for α3β1 integrin”, vol: 108, pp. 161-172.
Lugassy, et al., (1999), J. Cutaneuous Pathol., “Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis”, vol: 26, pp. 222-226.
Määttä, et al., (2001), The Journal of Histochemistry & Cytochemistry, “Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the α1 chain of laminin shows a selected expression pattern in human carcinomas”, vol: 49(6), pp. 711-725.
Määttä, et al., (1999), Journal of Pathology, “Expression of the laminin γ2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization”, vol: 188, pp. 361-368.
Manda, et al., (2000), Biochemical and Biophysical Research Communications, “Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas”, vol: 275, pp. 440-445.
Marinkovich, et al., (1992), JBC, “The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor”, vol: 267, pp. 17900-17906.
Martin, et al., (1998), Mol. Med., “Down-regulation of laminin-5 in breast carcinoma cells”, vol: 4(9), pp. 601-613.
Matsui, et al., (1995), J. Invest. Dermatology, “γ2 chain of Laminin-5 is recognized by Monoclonal Antibody GB3”, vol: 105, pp. 648-652.
Matsui, et al., (1995), JBC, “The Assembly of Laminin-5 Subunits”, vol: 270(40), pp. 23496-23503.
McMillan, et al., (1997), Br. J. Dermatol., “Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation”, vol: 136, pp. 817-822.
Mizushima, et al., (1998), Horm. Res., “Wide Distribution of Laminin-5 γchain in basement membranes of various human tissues”, vol: 50 (Suppl. 2), pp. 7-14.
Mizushima, et al., (1996), J. Biochem., “Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors”, vol: 120, pp. 1196-1202.
Moriya, et al., (2001), Cancer, “Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size”, vol: 19(6), pp. 1129-1141.
Niki, et al., (2002), American Journal of Pathology, “Frequent c
Kallunki Pekka
Pyke Charles
Tryggvason Karl
BioStratum, Inc.
Hines Ja'Na
McDonnell & Boehnen Hulbert & Berghoff
Smith Lynette R. F.
LandOfFree
Laminin chains: diagnostic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Laminin chains: diagnostic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Laminin chains: diagnostic uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449138